• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

217.22 +4.09 (+1.92%)
Streaming Delayed Price Updated: 3:54 PM EDT, Mar 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,034,896
Open 215.06
Bid (Size) 217.15 (500)
Ask (Size) 217.28 (200)
Prev. Close 213.12
Today's Range 214.85 - 219.17
52wk Range 164.39 - 244.81
Shares Outstanding N/A
Dividend Yield 3.19%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Corcept Therapeutics Outperforms: How a Surprise FDA Approval Ignited a Late-March Rally
Today 10:33 EDT
In a month characterized by macroeconomic headwinds and a broader cooling of the biotechnology sector, Corcept Therapeutics (NASDAQ: CORT) has emerged as a definitive outlier. While the S&P Biotech ETF... 
Via MarketMinute
Topics ETFs Intellectual Property Stocks
News headline image
Merck Just Made a Big Bet on a New Cancer Growth Engine ↗
Today 7:58 EDT
Via MarketBeat

Performance

YTD
-5.3%
-5.3%
1 Month
-7.3%
-7.3%
3 Month
-5.9%
-5.9%
6 Month
-2.7%
-2.7%
1 Year
+3.7%
+3.7%

More News

Read More
News headline image
This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks ↗
March 30, 2026
Via The Motley Fool
Topics ETFs Stocks
News headline image
1 Reason Eli Lilly Stock Is Still a Buy ↗
March 28, 2026
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Eli Lilly Shares Slip Despite Positive Eczema Trial Results: Why the Market Reacted Coolly
March 27, 2026
Via MarketMinute
News headline image
Here's How Many Shares of AbbVie (ABBV) Stock You'd Need for $10,000 in Yearly Dividends ↗
March 27, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
The 15-Minute Breakthrough: A Deep Dive into GH Research (GHRS) and the Future of Rapid-Acting Psychedelics
March 26, 2026
Via Finterra
Topics Cannabis Initial Public Offering Intellectual Property
News headline image
The Fed Is Worried About Trump-Fueled Inflation. Are Your Stocks Safe? ↗
March 25, 2026
Via The Motley Fool
Topics Economy Government World Trade
News headline image
What Is Considered a Good Stock Dividend? 2 Healthcare Stocks Fit the Bill. ↗
March 24, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Bristol-Myers Squibb Shares Jump 3.3% on Robust 2026 Guidance and High Dividend Yield
March 23, 2026
Via MarketMinute
Topics Economy Initial Public Offering Intellectual Property
News headline image
Why AbbVie Stock Looks Like a Dirt Cheap Buy Right Now ↗
March 23, 2026
Via The Motley Fool
Topics ETFs Intellectual Property
News headline image
FDA Approves Protagonist’s ICOTYDE: The Oral Peptide Revolution Hits the Psoriasis Market
March 23, 2026
Via MarketMinute
News headline image
Best Healthcare Stocks to Buy After the Market Pullback ↗
March 20, 2026
Via The Motley Fool
News headline image
The Smartest Dividend Stocks to Buy With $2,000 Right Now ↗
March 20, 2026
Via The Motley Fool
Topics Energy Intellectual Property
News headline image
AbbVie Shares Retreat to Multi-Month Lows Amid Competitive Headwinds and Technical Breakdown
March 18, 2026
Via MarketMinute
Topics ETFs Economy Intellectual Property
Top S&P500 movers in Wednesday's session ↗
March 18, 2026
Via Chartmill
Wednesday's session: top gainers and losers in the S&P500 index ↗
March 18, 2026
Via Chartmill
News headline image
What's Going On With AbbVie Stock Today? ↗
March 18, 2026
Via Benzinga
Wednesday's session: gap up and gap down stock in the S&P500 index ↗
March 18, 2026
Via Chartmill
News headline image
My Top 3 Dividend Kings to Buy for March 2026 ↗
March 17, 2026
Via The Motley Fool
News headline image
My 5 Favorite Dividend Stocks to Buy Right Now ↗
March 15, 2026
Via The Motley Fool
Topics Retirement
News headline image
Concorde Financial Exits Howard Hughes Holdings, Developer of Large Sun Belt Communities ↗
March 13, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
The Best Dividend Stocks to Buy and Hold Forever ↗
March 12, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Market Downturn: 2 Stocks to Buy and Hold Through Any Storm ↗
March 11, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Quiet Outperformance From an Overlooked Dividend ETF ↗
March 09, 2026
Via MarketBeat

Frequently Asked Questions

Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 217.22
When was AbbVie last traded?
The last trade of AbbVie was at 03/31/26 03:54 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap